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Abstract 
Objective: Diabetes substantially increases the risk of cardiovascular disease (CAD) and is associated with an 
increased risk of CAD mortality. The purpose of this study was to investigate the differences in coronary artery plaque, 
coronary artery calcification (CAC) measured in outpatients with and without type 2 diabetes, and the occurrence rate 
of a major adverse cardiac event (MACE) throughout follow-up with the same patients.
Methods: Five hundred eighty-eight outpatients with suspected CAD comprising 208 diabetic and 380 non-diabetic 
patients were enrolled in this study. Coronary artery plaque and CAC scores were detected and measured by dual-
source computed tomography. The major MACE during the follow-up period (4.0–20 months) was recorded and its 
relationship to type 2 diabetes and CAC was investigated.
Results: The diabetes group had higher CAC scores in the left anterior descending, left circumflex, and right coronary 
arteries and total CAC burden than the group without diabetes. The diabetes group had more diseased coronary 
segments and more obstructed vessels than the non-diabetes group. Logistic regression analysis demonstrated that 
diabetes is positively associated with mixed coronary plaque and non-calcified plaque. All patients in the diabetes 
group and all patients with higher CACs in both groups had a higher incidence rate of MACEs.
Conclusion: Patients with type 2 diabetes have a higher prevalence of obstructive CAD, higher CAC scores, and a 
higher incidence rate of MACEs than those without diabetes. Diabetes and higher CAC scores were the important 
predictors of the occurrence of MACEs throughout follow-up with patients.
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Background
Patients with type 2 diabetes have a two- to four-times-
higher risk of cardiovascular events and cardiovascu-
lar diseases (CVDs), in which coronary artery disease 
(CAD) is the major cause of death, than patients with-
out diabetes (Beckman et  al. 2002; Elkeles 2010). The 
pathophysiology of vascular disease in diabetics involves 
abnormalities in endothelial and vascular smooth muscle 
cells (VSMCs) and alterations in platelet function (Paneni 
et al. 2013; Howangyin and Silvestre 2014). Vascular cal-
cification is also more common in patients with diabetes 
(Abedin et  al. 2004; Parhami et  al. 1996; Shemesh et  al. 
2013; Hruska et  al. 2005). Coronary artery calcification 
(CAC) assessed by cardiac computed tomography (CT) is 
a well-established surrogate marker of the total burden of 
atherosclerosis, a disease in which plaque deposits build 
up in the arteries (Rumberger et al. 1995; Sangiorgi et al. 
1998; Greenland et al. 2010). CAC can predict CAD and 
the risk of cardiovascular events beyond the standard risk 
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factors (Budoff et al. 2006; Detrano et al. 2008). Although 
the association between diabetes and CAC is controver-
sial, several studies have indicated a significant relation-
ship between high CAC and diabetes (Elkeles et al. 2008; 
Bulugahapitiya et  al. 2009; Qu et  al. 2003; Raggi et  al. 
2004); however, studies on the relationship between CAC 
and diabetes and major adverse cardiac events (MACEs) 
in Chinese patients are rare. In this study, we measured 
CAC in patients with and without diabetes to investigate 
the differences in coronary artery plaque, CAC in outpa-
tients with and without diabetes, and the occurrence rate 
of MACEs during follow-up time in the same patients.
Patients and methods
Study population
The study protocol was approved by the Ethics Com-
mittee of the Zhengzhou University People’s Hospital. 
All patients were given an informed consent form that 
was approved by the Ethics Committee before being 
enrolled in this study. Six hundred fifteen consecutive 
Chinese outpatients with and without diabetes were 
surveyed. And all of the diabetes were the type 2 diabe-
tes. Three ways to diagnose diabetes are possible before 
they were treated dietary intervention, oral glucose-
lowing medication or insulin: (1).Symptoms of diabetes 
plus casual plasma glucose concentration ≥200  mg/dl 
(11.1 mmol/l). Casual is defined as any time of day with-
out regard to time since last meal. The classic symptoms 
of diabetes include polyuria, polydipsia, and unexplained 
weight loss; (2).Fasting plasma glucose (FPG) ≥126 mg/
dl (7.0  mmol/l). Fasting is defined as no caloric intake 
for at least 8 h; (3) 0.2-h plasma glucose (PG) ≥200 mg/
dl (11.1  mmol/l) during an oral glucose tolerance test 
(OGTT) using a glucose load containing the equivalent of 
75 g anhydrous glucose dissolved in water (Expert Com-
mittee on the Diagnosis and Classification of Diabetes 
Mellitus 2003). All patients with suspected CAD (defined 
when patients had symptoms such as atypical chest pain, 
chest tightness, shortness of breath, or an atypical change 
in the ST–T wave on an electrocardiography) underwent 
dual source computed tomography (DSCT) because of 
uncomfortable symptoms (chest pain, chest tightness, 
shortness of breath, palpitations) at Zhengzhou Univer-
sity People’s Hospital between June 2012 and February 
2014. Of these patients, 27 (4.4 %) were lost during fol-
low-up; therefore, baseline and follow-up data were avail-
able for only 588 patients. A complete patient history 
comprising present and previous illnesses was recorded 
and a complete physical examination was conducted.
Study criteria
The exclusion criteria were a history of thyroid problems, 
history of CAD, serious cardiac arrhythmias, chronic 
kidney and hepatic diseases, poor CT scan quality, and 
a history of coronary artery stenting or bypass. And the 
type 1 diabetes were excluded. Known CAD was defined 
as a history of diagnosed myocardial infarction or the 
presence of coronary artery luminal narrowing >50  % 
documented by angiography.
Laboratory tests
Blood samples were collected within 24 h before or after 
DSCT to detect the following laboratory parameters: 
total cholesterol, triglycerides, high-density lipoprotein 
(HDL-C), low-density lipoprotein (LDL-C), lipoprotein a 
(LPa), and cystatin C (CYSC) after the patients had fasted 
for at least 12  h. The reference ranges of HDL-C, LDL-
C, LPa, CYSC in use in our laboratory are as follows: 
HDL-C =  1.2–1.68  mmol/l, LDL-C =  1.9–3.12  mmol/l, 
LPa = 0–30 mg/dl, CYSC = 0.55–1.05 mg/l.
Dual‑source CT angiography
DSCTs were performed using a SOMATOM Defini-
tion DSCT scanner (Siemens Medical Solutions, Forch-
heim, Germany). Each patient enrolled in the study was 
in normal sinus rhythm at the time of the DSCT scan; 
therefore, a beta-blocker was not needed to reduce the 
heart rate (Zimmerman et  al. 2014). A non-enhanced 
scan was performed for CAC scoring. The scanning 
area extended from the level of the tracheal bifurcation 
to the diaphragm. A 70- to 90-ml bolus of iopamidol 
(370 mg of iodine/ml; Bracco Sine Pharmaceutical Corp. 
Ltd, Shanghai, China) was injected into the antecubi-
tal vein at a flow rate of 5.0  ml/s. Slices were acquired 
under the following conditions: tube voltage 100–120 kV 
(adapted to body mass index [BMI]); tube current, 
220  mA; collimation, 64  ×  0.6  mm, slice collimation 
2.0  ×  64  ×  0.6  mm by means of a z-flying focal spot; 
rotation time, 0.33  s; and pitch, 0.2–0.5 depending on 
heart rate.
Image analysis
DSCTA images were interpreted by two experienced car-
diovascular radiologists blinded to all patient characteris-
tics. CAC was quantified using Syngo CaScore (Siemens 
Medical Solutions, Forchheim, Germany) and the scores 
were measured by a CT technologist using the stand-
ard Agatston calcium scoring algorithm (Agatston et al. 
1990).
Coronary plaque assessment
According to American Heart Association standards, 
coronary arteries were divided into 15 segments ana-
tomically (Austen et  al. 1975). In this study, we divided 
the coronary arteries into the following four branches: 
left main (LM), left anterior descending (LAD), left 
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circumflex (LCX), and right (RCA). We evaluated the 
number of diseased coronary vessels and segments of 
each branch and total coronary artery, number, and 
types of diseased segments, and the number of obstruc-
tive or non-obstructive segments. Plaques are classified 
as (A) calcified plaque: higher CT density than contrast-
enhanced lumen; (B) non-calcified plaque: without any 
calcified portions (≦130  HU). (C) mixed plaques: non-
calcified and calcified component in single plaque. The 
differences in the distribution of the three plaque sub-
types were compared between patients with and without 
diabetes. DSCT on each patients was also scored on a 
per-segment basis for plaque stenosis severity. A steno-
sis of ≥50  % was considered obstructive CAD and the 
segment was considered to be an obstructive segment. 
The number of segments that contained all three plaque 
subtypes was calculated for each patients. Per coronary 
segment was assigned by one coronary plaque type. 
They were classified as mixed plaque when both mixed 
(or calcified) and non-calcified plaques were seen in one 
segment.
Patient follow‑up
Follow-up information was obtained from patient 
records in outpatient clinics and from telephone inter-
views with the patients or their immediate relatives. All 
interviews were conducted by the same cardiologist and 
he was blinded for status diabetes. The primary endpoint 
at follow-up was the incidence of MACEs, including 
death from any cause, such as nonfatal myocardial infarc-
tion (MI); percutaneous coronary intervention; and coro-
nary artery bypass graft. Nonfatal MI was defined as the 
presence of typical chest pain, electrocardiographic ele-
vation of the ST segment with or without Q waves, and 
serum cardiac enzyme elevation at least twice that of the 
normal upper limit.
Statistical analyses
All statistical analyses were performed using SPSS ver-
sion 17.0 (SPSS. Inc., Chicago, IL, USA). Continuous 
variables are expressed as the mean ± standard deviation 
and categorical variables are described using number 
and percentage. The Student’s t test was used to compare 
continuously normal variables and the Mann–Whitney 
U test was used for continuously abnormal variables; a 
Chi squared test was used for categorical variables. The 
difference in the presence of the three subtype plaque 
segments were compared using cox regression model to 
adjust for diabetes, sex, age, BMI, LDL levels, HDL lev-
els, and LPa. The cumulative event rate was evaluated 
using a Kaplan–Meier estimate and compared using a 
log-rank test. P < 0.05 was considered to be statistically 
significant.
Results
After screening, 588 patients (comprising 372 men) aver-
age aged 61.06 ± 11.89 years and of whom 208 had diabe-
tes were followed for 14.33 ± 2.59 months. Clinical and 
biochemical characteristics are shown in Table  1. The 
diabetes group (n  =  208) had significantly higher BMI 
(p = 0.001), LPa (p = 0.044), and CYSC levels (p = 0.002); 
however, this group had fewer men (p = 0.016) and lower 
HDL-C levels (p  <  0.001) than the group without dia-
betes. No significant difference was observed between 
the two study groups for age; hypertension; TG, CHOL, 
LDL-C, apolipoprotein A-I (APOA1), APOA100, and 
homocysteine levels; and the proportion of patients with 
a history of smoking. In this study, parts of patients of 
both diabetes and non-diabetes groups had the history 
of stains use, although the cholesterol and APO measure-
ments might be influenced by stains use, no significant 
difference was observed between the two study groups 
for stains use but glucose-lowering drugs.
Significant differences in CAC levels between patients 
with and without diabetes were observed (Table 2). The 
diabetes group had significantly higher CAC scores 
in LAD (155.03  ±  256.47 vs. 92.78  ±  195.72, respec-
tively; p = 0.003), LCX (39.11 ± 67.74 vs. 22.97 ± 52.90, 
respectively; p  =  0.003), RCA (88.82  ±  172.39 vs. 
32.38  ±  70.40, respectively; p  <  0.001), and total CAC 
scores (309.00 ± 457.14 vs. 180.09 ± 290.62, respectively; 
p  <  0.001) than that in the non-diabetes group, but no 
differences were found in LM CAC levels between the 
two groups.
The diabetes group had a significantly higher number 
of mixed plaque segments (2.72 ±  2.45 vs. 1.69 ±  2.12, 
respectively; p  <  0.001), non-calcified plaque segments 
(0.87  ±  1.36 vs. 0.49  ±  0.97, respectively; p  <  0.001), 
and total plaque segments (4.76 ±  3.10 vs. 3.36 ±  2.58, 
respectively; p < 0.001) than the non-diabetes group, but 
no differences were observed in levels of calcified plaque 
between the two groups (Table 3). There were a signifi-
cantly higher number of obstructed vessels (1.00 ± 1.02 
vs. 0.54 ±  0.81, respectively; p  <  0.001) and obstructed 
segments (1.92  ±  2.24 vs. 0.77  ±  1.34, respectively; 
p < 0.001) in the diabetes group than in the non-diabetes 
group.
Mixed plaques were significantly associated with 
age [odds ratio (OR) 1.029, 95  % confidence level (CI) 
1.014–1.044, p  <  0.001], diabetes (OR 1.796, 95  % CI 
1.246–2.589, p = 0.002), and LDL-C (OR 2.041, 95 % CI 
1.567–2.657, p = 0.002) (Table 4). Non-calcified plaques 
were significantly associated with diabetes (OR 1.574, 
95  % CI 1.101–2.250, p  =  0.013), and calcified plaques 
were significantly associated with age (OR 1.071, 95 % CI 
1.054 to −1.088, p < 0.001) and BMI (OR 1.12, 95 % CI 
1.029–1.141, p = 0.002).
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According to the multivariate analyses, diabetes [haz-
ard ratio (HR) = 1.136–3.753, p = 0.017] and CAC levels 
(HR = 1.000–1.002, p = 0.002) were independent predic-
tors of cumulative MACEs (Table 5).
Kaplan–Meier survival curves for the incidence of 
MACEs in patients with diabetes versus those with-
out diabetes are shown in Fig.  1 (p  =  0.002). Cumula-
tive MACE-free survival curves among groups with 
CAC scores  <  100, 100  ≤  C CAC scores  ≤  400, and 
400  <  CAC scores are shown in Fig.  2 (p  <  0.001). The 
same relationships among groups with CAC scores < 100, 
100  ≤  CAC scores  ≤  400, and 400  <  CAC scores in 
the diabetes group are shown in Fig.  3 (p  <  0.001) and 
those in the non-diabetes group are showed in Fig.  4 
(p = 0.004).
Discussion
First, the present study demonstrated that diabetes 
is related to higher levels of CAC in outpatients with 
suspected CAD. Second, diabetes is related to mixed 
Table 1 Clinical characteristics in diabetes and non-diabetes groups
Data are expressed as the mean ± SD and number (percentage)
BMI body mass index, CHOL cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, APO apolipoprotein, 
LPa lipoprotein a, HCY homocysteine, T score total coronary artery calcification scores, MI myocardial infarction
Variables Total (N = 588) Diabetes (N = 208) Non‑diabetes (N = 380) p
Age (years) 61.06 ± 11.89 61.91 ± 10.57 60.60 ± 12.55 0.179
Sex, male (%) 372 (63.3) 118 (56.7) 254 (66.8) 0.016
Hypertension [n (%)] 380 (64.6) 141 (67.8) 239 (62.9) 0.242
Smoking [n (%)] 264 (44.9) 86 (41.3) 178 (46.8) 0.225
BMI (Kg/m2) 25.54 ± 3.480 26.11 ± 2.668 25.23 ± 3.821 0.001
CHOL (mmol/l) 4.70 ± 0.934 4.78 ± 0.967 4.66 ± 0.915 0.170
TG (mmol/l) 1.70 ± 1.309 1.79 ± 1.168 1.65 ± 1.379 0.232
HDL-C (mmol/l) 1.19 ± 0.320 1.12 ± 0.304 1.22 ± 0.323 <0.001
LDL-C (mmol/l) 2.67 ± 0.691 2.74 ± 0.737 2.63 ± 0.663 0.078
APOA1 (g/l) 1.15 ± 0.229 1.14 ± 0.224 1.16 ± 0.232 0.458
APOA100 (g/l) 0.95 ± 0.261 0.96 ± 0.227 0.95 ± 0.277 0.463
LPa (mg/dl) 21.97 ± 17.800 23.97 ± 17.910 20.88 ± 17.668 0.044
HCY (µmol/l) 17.89 ± 8.533 17.12 ± 6.577 18.31 ± 9.416 0.074
CYSC (mg/l) 0.97 ± 0.282 1.02 ± 0.340 0.94 ± 0.240 0.002
Table 2 Comparison of coronary artery calcification between diabetes and non-diabetes
LM left main, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, CAC coronary artery calcification
Variables Total (N = 588) Diabetes (N = 208) Non‑diabetes (N = 380) p
LM CAC scores 29.22 ± 116.71 22.44 ± 63.59 32.94 ± 137.30 0.207
LAD CAC scores 114.95 ± 221.10 155.03 ± 256.47 92.78 ± 195.72 0.003
LCX CAC scores 28.68 ± 59.03 39.11 ± 67.74 22.97 ± 52.90 0.003
RCA CAC scores 52.34 ± 120.04 88.82 ± 172.39 32.38 ± 70.40 <0.001
Total CAC scores 225.69 ± 363.36 309.00 ± 457.14 180.09 ± 290.62 <0.001
Table 3 Comparison of coronary artery plaque between diabetes and non-diabetes patients
Variables Total (N = 588) Diabetes (N = 208) Non‑diabetes (N = 380) p
Number of mixed plaque segments 2.05 ± 2.29 2.72 ± 2.45 1.69 ± 2.12 <0.001
Number of calcified plaque segments 1.18 ± 1.67 1.18 ± 1.70 1.18 ± 1.66 0.991
Number of non-calcified plaque segments 0.63 ± 1.14 0.87 ± 1.36 0.49 ± 0.97 <0.001
Total plaque segments 3.85 ± 2.85 4.76 ± 3.10 3.36 ± 2.58 <0.001
Number of obstructive vessels 0.70 ± 0.92 1.00 ± 1.02 0.54 ± 0.81 <0.001
Number of obstructive segments 1.18 ± 1.80 1.92 ± 2.24 0.77 ± 1.34 <0.001
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plaque, non-calcified plaque, and the extent of coronary 
artery stenosis. After an adjustment for conventional 
risk factors, the relationship remained significant. Third, 
diabetes and CAC levels were significantly related to the 
incidence rate of MACEs in our patients. The results of 
this study suggested that diabetes was positively related 
to the extent of CAC and coronary artery stenosis, and 
both diabetes and CAC were positively related to the 
incidence rate of MACEs in Chinese outpatients with 
suspected CAD.
Several studies have shown that CAD is a leading cause 
of morbidity and mortality among patients with diabe-
tes (Scholte et  al. 2008; Haffner et  al. 1998). Compared 
with people without diabetes, people with diabetes have 
nearly double the risk of cardiovascular disease, even 
after adjusting for established cardiovascular risk factors 
(Seshasai et  al. 2011). The pathophysiology of vascular 
disease in patients with diabetes involves abnormalities 
in endothelial cells and VSMCs, and alterations in plate-
let function (Paneni et al. 2013; Howangyin and Silvestre 
2014). CAC scores are not only a sign of atherosclerosis 
used to predict the likelihood of significant CAD and 
myocardial ischemia, but also an indicator of the total 
coronary atherosclerotic plaque burden (Rumberger et al. 
1995). Vascular calcification is more common in patients 
with diabetes, which is an active process associated with 
complex genetic, cellular, and molecular pathways, and 
the disease in patients with diabetes might be related to 
Table 4 Predictors of  coronary plaque by  Cox regression 
model
OR odds ratio, CI confidence interval, LDL-C low-density lipoprotein cholesterol, 
BMI body mass index
Plaques Variables OR 95 % CI p
Mixed plaque Age 1.029 1.014–1.044 <0.001
Diabetes 1.796 1.246–2.589 0.002
LDL-C 2.041 1.567–2.657 <0.001
Non-calcified plaque Diabetes 1.574 1.101–2.250 0.013
Calcified plaque Age 1.071 1.054–1.088 <0.001
BMI 1.12 1.029–1.141 0.002
Table 5 Multivariate analysis of  predictors of  incidence 
rate of major adverse cardiac event
CAC coronary artery calcification, HR hazard ratio, CI confidence interval
Variables HR 95 % CI p
Diabetes 2.065 1.136–3.753 0.017
CAC scores 1.001 1.000–1.002 0.002
Fig. 1 Cumulative major adverse cardiac event–free survival curves between diabetes and non-diabetes groups. MACE major adverse cardiac event
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biochemical changes (Snell-Bergeon et al. 2013; Boström 
et  al. 2011). Chen et  al. (2006) and Zhang et  al. (2008) 
found that high serum glucose levels are associated 
with an increased expression of Cbfal and BMP-2 and 
enhanced the calcification of VSMCs. Increased levels of 
BMP-2 exert proinflammatory and proatherogenic effects 
by inducing oxidative stress and endothelial dysfunction, 
and have been shown to promote plaque calcification by 
inducing an osteogenic phenotype in VSMCs (Willette 
et al. 1999; Li et al. 2008). In this study, we found a simi-
lar conclusion that higher CAC scores in outpatients with 
suspected CAD are related to diabetes, and that oxida-
tive stress and endothelial dysfunction induced by BMP-2 
might be the important intermediate links.
In this study, we found that diabetes is related to mixed 
plaque, non-calcified plaque, and the extent of coronary 
artery stenosis. One study on diabetes and coronary 
artery plaques showed that non-calcified plaques are the 
main subtype in asymptomatic diabetes patients com-
pared with those without diabetes (Scholte et  al. 2008), 
which agrees with our research. In several studies, intra-
vascular ultrasound and magnetic resonance imaging 
were used to detect the composition of plaque (Schartl 
et al. 2001; Hong et al. 2010; Qian et al. 2009; Koops et al. 
2007), and the mixed plaques detected by coronary com-
puted tomography angiography (CCTA) were associated 
with high-risk features (Pundziute et  al. 2008). Thin-
cap fibroatheromas occurred more frequently in mixed 
plaques than in non-calcified and calcified plaques. A 
recent study demonstrated that patients with diabe-
tes had an increased number of obstructive and mixed 
plaque segments compared to patients without diabetes 
(Pundziute et  al. 2008). Our study is in agreement with 
all of the cited studies that showed that there is a higher 
plaque burden and extent of atherosclerosis in patients 
with diabetes compared to those without diabetes. We 
found that there is a relatively more non-calcified plaque 
burden in patients with diabetes than in those without 
diabetes. Several studies have also confirmed the effect 
of diabetes on vulnerable plaque and acute coronary syn-
drome (ACS) (Stamler et  al. 1993; Leschka et  al. 2008). 
Unstable non-calcified plaque, was vulnerable and fre-
quently detected in patients with ACS. We did not find 
any differences in the number of calcified plaque seg-
ments between the two groups, but the scores of coro-
nary calcium were significantly different. These results 
might be because the volume and quality of some cal-
cified plaques were greater in patients with diabetes 
Fig. 2 Cumulative major adverse cardiac events–free survival curves among patients with coronary artery calcium scores (CAC scores) < 100, 
100 ≤ CAC scores ≤ 400 and 400 < CAC scores. MACE major adverse cardiac event
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Fig. 3 Cumulative major adverse cardiac event (MACE)–free survival curves among patients with coronary artery calcium scores (CAC scores) < 100, 
100 ≤ CAC scores ≤ 400, and 400 < CAC scores in the diabetes group. MACE major adverse cardiac event
Fig. 4 Cumulative major adverse cardiac event (MACE)–free survival curves among patients with coronary artery calcium scores (CAC scores) < 100, 
100 ≤ CAC scores ≤ 400, and 400, CAC scores in the non-diabetes group. MACE major adverse cardiac event
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than in those without diabetes, but this remains to be 
determined.
We discovered that diabetes and CAC are significantly 
related to the incidence rate of MACEs in our patients. 
Diabetes and high CAC scores might increase the inci-
dence of short-term and long-term major adverse cardiac 
events through some of the pathways mentioned above. 
Diabetes is a predictive factor for MACEs, and we found 
that high CAC scores are a predictive factor for MACEs 
in the groups with and without diabetes. These results 
are similar to those of other studies on the effect of diabe-
tes on MACEs during the following-up time.
Study limitations
This study had several limitations. The study population 
comprised outpatients and, consequently, complete data 
on some parameters were not collected. As a result, it is 
possible that other factors that were potentially associ-
ated with CAC were not identified. This study was based 
on a single center. Larger studies that comprise a more 
diverse population would be needed to verify these find-
ings. In this study, the prognostic value of CCTA in dia-
betes and non-diabetes patients was not determined, and 
more studies are needed to determine this value in this 
group of patients.
Conclusion
Patients with diabetes have a higher prevalence of 
obstructive CAD, higher CAC scores, and a higher 
incidence rate of MACEs than those without diabetes. 
Diabetes and higher CAC scores are the important pre-
dictors of the occurrence of MACEs during follow-up.
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